Smoking Cessation Products Market , 2018-2028 by Segmentation: Based on Product, Application and Region

Key Insights

Growing Prevalence of Chronic Obstructive Pulmonary Disease (COPD) Drives Demand for Smoking Cessation Products

A prevalence of around 251 million patients with COPD was report across the globe in 2016 by a WHO report, and it will become the third leading cause of death by 2030. As smoking tobacco is the primary cause of COPD, manufacturers in the smoking cessation products market are promoting the use of various types of smoking cessation products to prevent it.

Additionally, consumers are becoming aware that there is no cure for the life-threatening disease, thereby, the growing needs for preventing COPD is boosting adoption of smoking cessation products. Offering personalized smoking cessation products to facilitate COPD management for patients can help smoking cessation products market players to improve sales and gain an edge in the smoking cessation products market in coming years.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2372

Competitive Landscape:

The Fact.MR report on smoking cessation products market enlists leading stakeholders in the market to provide insightful information about recent developments in the winning strategies of leading competitors in the smoking cessation products market. This chapter features comprehensive information, including intensity mapping, key financials, market share analysis, key developments, SWOT analysis, SIC, NACE, & NIACS codes, and global manufacturing facilities, about the each smoking cessation products market player mentioned above. The report provides detailed information about the leading market players including Johnson & Johnson Inc., GlaxoSmithKline plc, Pfizer, Inc, Perrigo Company plc, Cipla Ltd., ITC Limited, Reynolds American Inc., Imperial tobacco ltd., Fertin Pharma, and Alkalon A/S.

Johnson & Johnson Development Corp., a frontrunner in the smoking cessation products market, recently joined Carrot Inc., a digital health company New York Life Ventures and to raise over US$ 25 million to commercialize Pivot™ – smoking cessation program. The company is contributing to the project with its technological expertise in the medical device and pharmaceutical sector to establish stronger position in the smoking cessation products market.

Another frontrunner in the smoking cessation products market, GlaxoSmithKline plc. announced, in collaboration with an American pharmaceutical company – Innoviva, Inc., that the European Commission has authorized expansion of its single inhaler triple therapy – once-daily Trelegy Ellipta. The company is aiming to adopt innovative strategies to offer an inhaler therapy for COPD patients and strengthen its foothold in the smoking cessation products market.

Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2372

Imperial Brands PLC, a British player in smoking cessation products market, has adopted strategies to focus on its blu e-cigarette brand by investing over GBP100 million for further expanding its e-cigarette product portfolio in the coming year. Via its subsidiary Fontem Ventures, the company launched its new e-smoking cessation product– myblu™ in the U.S. in February 2018, and later in three further markets – France, Russia, and Germany. With launch of the new e-smoking cessation product, Imperial Brands is aiming to set a benchmark in the e-vaporing category of products in the smoking cessation market.

Other players in the smoking cessation products market, including Cipla Ltd., are adopting innovative marketing strategies, such as promotions of social media and unique commercials to spread awareness about tobacco hazards, to boost sales of their smoking cessation products.

The Fact.MR market report on the smoking cessation products market features a detailed analysis of the market, including information on the most interesting developments in the smoking cessation products market across the globe. The report provides an overview of the smoking cessation products market, analysis of the latest trends in the smoking cessation products market, along with a section with information about new avenues of growth for manufacturers and distributors in the smoking cessation products market.

Segmentation

The smoking cessation products market is segmented on the basis of geographical regions, product type, and sales channel. Each segment is divided into sub-segments for the better understanding of readers about growth parameters the smoking cessation products market.

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=2372

Additional Questions Answered

The Fact.MR report provides accurate information about how the smoking cessation market is expanding across the globe and its growth prospects. This information can help market players to understand the minute details about how other smoking cessation products market players are paving their way through the smoking cessation market along with detailed information about their winning strategies.

The information presented in the smoking cessation market report answered important market-related questions for market leaders as well as new entrants in the smoking cessation product, which can help them to make appropriate business decisions in the coming future. Some of the questions include

Which region is expected to dominate the smoking cessation products market?
Which category of buyers are more interested in purchasing smoking cessation products?
What strategies smoking cessation products market players should adopt to gain momentum in the market?
What type of product is likely to hold the largest share in the smoking cessation products market?
What are the factors restricting the growth of the smoking cessation products market?
Access This Report @ https://www.factmr.com/checkout/2372/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.